Synthesis, enzymatic hydrolysis, and anti-HIV activity of AZT-spacer-curdlan sulfates

被引:23
作者
Gao, Y
Katsuraya, K
Kaneko, Y
Mimura, T
Nakashima, H
Uryu, T
机构
[1] Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan
[2] Kagoshima Univ, Sch Dent, Kagoshima 8908544, Japan
[3] Ajinomoto Co Inc, Chuo Ku, Tokyo 1040031, Japan
[4] Teikyo Univ Sci & Technol, Yamanashi 4090193, Japan
关键词
D O I
10.1021/ma990782k
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
An AIDS (acquired immunodeficiency syndrome) drug, azidothymidine (AZT), was bound by an ester bond onto curdlan sulfate having both anti-HIV activity and the property of accumulating in lymphoid tissues to produce a series of biodegradable AZT-aliphatic-dicarboxylate-curdlan sulfates (designated as AZT-spacer-curdlan sulfates). When the carbon number of the alkylene group was 2-12, AZT-spacer-curdlan sulfates exhibited high anti-HIV activities in the EC50 range of 0.04-0.21 mu g/mL and low cytotoxicities of CC50 of more than 1000 mu g/mL. AZT-dodecanedicarboxylate-curdlan sulfate with the highest anti-HIV activity was easily hydrolyzed by esterase-enzymatic hydrolysis to release free AZT. Furthermore, an acidically released AZT from curdlan sulfate exhibited its high anti-HIV activity. AZT-dodecanedicarboxylate-curdlan sulfate showed a low anticoagulant activity of 7 unit/mg.
引用
收藏
页码:8319 / 8324
页数:6
相关论文
共 23 条
[1]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[2]   AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor [J].
Donzella, GA ;
Schols, D ;
Lin, SW ;
Esté, JA ;
Nagashima, KA ;
Maddon, PJ ;
Allaway, GP ;
Sakmar, TP ;
Henson, G ;
De Clercq, E ;
Moore, JP .
NATURE MEDICINE, 1998, 4 (01) :72-77
[3]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362
[4]   MULTIFACTORIAL NATURE OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - IMPLICATIONS FOR THERAPY [J].
FAUCI, AS .
SCIENCE, 1993, 262 (5136) :1011-1018
[5]   PHARMACOKINETICS, TOXICITY, AND ACTIVITY OF INTRAVENOUS DEXTRAN SULFATE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
FLEXNER, C ;
BARDITCHCROVO, PA ;
KORNHAUSER, DM ;
FARZADEGAN, H ;
NERHOOD, LJ ;
CHAISSON, RE ;
BELL, KM ;
LORENTSEN, KJ ;
HENDRIX, CW ;
PETTY, BG ;
LIETMAN, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) :2544-2550
[6]   Synthesis of azidothymidine-bound curdlan sulfate with anti-human immunodeficiency virus activity in vitro [J].
Gao, Y ;
Katsuraya, K ;
Kaneko, Y ;
Mimura, T ;
Nakashima, H ;
Uryu, T .
POLYMER JOURNAL, 1998, 30 (01) :31-36
[7]  
Gordon M, 1997, J MED, V28, P108
[8]  
GORDON M, 1994, J MED, V25, P163
[9]   SYNTHESIS OF NEW HEPARINOIDS WITH HIGH ANTICOAGULANT ACTIVITY [J].
HATANAKA, K ;
YOSHIDA, T ;
MIYAHARA, S ;
SATO, T ;
ONO, F ;
URYU, T ;
KUZUHARA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (05) :810-814
[10]   RAPID TURNOVER OF PLASMA VIRIONS AND CD4 LYMPHOCYTES IN HIV-1 INFECTION [J].
HO, DD ;
NEUMANN, AU ;
PERELSON, AS ;
CHEN, W ;
LEONARD, JM ;
MARKOWITZ, M .
NATURE, 1995, 373 (6510) :123-126